亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會(huì)員登錄|免費(fèi)注冊(cè)|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購(gòu)物車
企業(yè)會(huì)員第1年

武漢遠(yuǎn)城科技發(fā)展有限公司銷售八部  

肉桂酸、肉桂醛、肉桂醇、及公司經(jīng)營(yíng)的生物化工、醫(yī)藥中間體等產(chǎn)品

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人:劉
  • 電話:02788320827
  • 郵件:yucheng011@yuanchengdope.com
  • 傳真:02788048077
  • QQ:172616357
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
替諾昔康
單價(jià) 面議對(duì)比
詢價(jià) 暫無
發(fā)貨 湖北武漢市付款后3天內(nèi)
過期 長(zhǎng)期有效
更新 2011-04-16 11:44
 
詳細(xì)信息

替諾昔康 
英文名稱: Tenoxicam 
CAS: 59804-37-4 
化學(xué)名稱: 4-hydroxy-2-methyl-N-2—pyridinyl-2H-thieno[2,3-e]-1,2-thiazine-3-carboxamide 1,1-dioxide 
分子式: C14H10N3O4S2 
分子量:337.4
外觀黃色結(jié)晶性粉末
含量≥99%
用途: 新型解熱鎮(zhèn)痛類藥物。本品可用于婦產(chǎn)科、口腔拔牙、
矯形手術(shù)及外科術(shù)后急性疼痛、外傷引起的中~重度疼痛、
急性坐骨神經(jīng)痛和腰痛、晚期癌痛,亦可用于慢性腰痛、
骨關(guān)節(jié)炎、類風(fēng)濕關(guān)節(jié)炎和強(qiáng)直性脊椎炎的治療 
包裝規(guī)格: 1kg 5kg 25kgDRUM 
質(zhì)量標(biāo)準(zhǔn): BP2003 
Tenoxicam
CAS: 59804-37-4
Chemical Name: 4-hydroxy-2-methyl-N-2-pyridinyl-2H-thieno [2,3-e] -1,2-thiazine-3-carboxamide 1,1-dioxide
Molecular formula: C14H10N3O4S2
Molecular weight: 337.4
Appearance of the yellow crystalline powder
Content ≥ 99%
Packing: 25kg cardboard drum
Uses: New anti-inflammatory drugs. Can be used in obstetrics
and gynecology, dental extractions, orthopedic surgery and 
acute pain after surgery, trauma caused by moderate to severe pain,
acute sciatica and low back pain, latePain can also be used for 
chronic low back pain, osteoarthritis, rheumatoid arthritis 
and ankylosing spondylitis treatment
Quality Standard: BP2003 

©2025 武漢遠(yuǎn)城科技發(fā)展有限公司銷售八部 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:27677  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |